Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report)’s stock price was down 20% on Thursday . The stock traded as low as C$1.24 and last traded at C$1.24. Approximately 500 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 8,000 shares. The stock had previously closed at C$1.55.
Genscript Biotech Stock Down 20.0 %
The firm’s fifty day simple moving average is C$1.31 and its two-hundred day simple moving average is C$1.41.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- What is a Stock Market Index and How Do You Use Them?
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- What Investors Need to Know About Upcoming IPOs
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Do ETFs Pay Dividends? What You Need to Know
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
